Association of polyfluoroalkyl chemical exposure with serum lipids in children

Science of the Total Environment

Volumn 512-513, Issue , 2015, Pages 364-370

  Zeng, Xiao Wen ^a   Qian, Zhengmin ^b   Emo, Brett ^b   Vaughn, Michael ^b   Bao, Jia ^c   Qin, Xiao Di ^a   Zhu, Yu ^a   Li, Jie ^a   Lee, Yungling Leo ^d   Dong, Guang Hui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SAINT LOUIS UNIVERSITY   (United States)

^c SHENYANG UNIVERSITY OF TECHNOLOGY   (China)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Children; Polyfluoroalkyl compounds; Polyfluoroalkyl substances; Serum lipids

Indexed keywords

LIPIDS; LIPOPROTEINS; REGRESSION ANALYSIS;

CHILDREN; HIGH-DENSITY LIPOPROTEINS; LOW DENSITY LIPOPROTEINS; PERFLUOROOCTANE SULFONIC ACIDS; PERFLUOROTETRADECANOIC ACID; POLYFLUOROALKYL COMPOUNDS; POLYFLUOROALKYL SUBSTANCES; SERUM LIPID;

BODY FLUIDS;

ALKANE DERIVATIVE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PERFLUORODECANOIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROTETRADECANOIC ACID; POLYFLUOROALKYL SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; FLUOROCARBON; LIPID; OCTANOIC ACID DERIVATIVE; PERFLUOROOCTANOIC ACID; POLLUTANT;

BIOACCUMULATION; CHEMICAL COMPOUND; LIPID; POLYMER; SERUM;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; LIMIT OF QUANTITATION; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; TAIWANESE; ANALYSIS; BLOOD; METABOLISM; POLLUTANT; PRESCHOOL CHILD;

ALKANESULFONIC ACIDS; CAPRYLATES; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; LIPIDS; MALE;

EID: 84921913938     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.01.042     Document Type: Article

References (56)

1. Abbott B.D., Wolf C.J., Schmid J.E., Das K.P., Zehr R.D., Helfant L., et al. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. Toxicol. Sci. 2007, 98:571-581.
2. Bao J., Liu W., Liu L., Jin Y., Dai J., Ran X., et al. Perfluorinated compounds in the environment and the blood of residents living near fluorochemical plants in Fuxin, China. Environmental Science & Technology 2010, 45:8075-8080.
3. Bao J., Lee Y., Chen P.-C., Jin Y.-H., Dong G.-H. Perfluoroalkyl acids in blood serum samples from children in Taiwan. Environ. Sci. Pollut. Res. 2014, 21:7650-7655.
4. Beesoon S., Genuis S.J., Benskin J.P., Martin J.W. Exceptionally high serum concentrations of perfluorohexanesulfonate in a Canadian family are linked to home carpet treatment applications. Environmental Science & Technology 2012, 46:12960-12967.
5. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 2001, 60:44-55.
6. Buck R.C., Franklin J., Berger U., Conder J.M., Cousins I.T., de Voogt P., et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr. Environ. Assess. Manag. 2011, 7:513-541.
7. Buhrke T., Kibellus A., Lampen A. In vitro toxicological characterization of perfluorinated carboxylic acids with different carbon chain lengths. Toxicol. Lett. 2013, 218:97-104.
8. Butenhoff J.L., Chang S.-C., Olsen G.W., Thomford P.J. Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology 2012, 293:1-15.
9. Butenhoff J.L., Kennedy G.L., Chang S.-C., Olsen G.W. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicology 2012, 298:1-13.
10. Butenhoff J.L., Pieterman E., Ehresman D.J., Gorman G.S., Olsen G.W., Chang S.-C., et al. Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractions. Toxicol. Lett. 2012, 210:360-365.
11. Château-Degat M.-L., Pereg D., Dallaire R., Ayotte P., Dery S., Dewailly É. Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (Northern Quebec). Environ. Res. 2010, 110:710-717.
12. Costa G., Sartori S., Consonni D. Thirty years of medical surveillance in perfluooctanoic acid production workers. J. Occup. Environ. Med. 2009, 51:364-372. 10.1097/JOM.0b013e3181965d80.
13. D'eon J.C., Mabury S.A. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?. Environmental Science & Technology 2011, 45:7974-7984.
14. Dong G., Tung K., Tsai C., Liu M., Wang D., Liu W., et al. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ. Health Perspect. 2013, 121:507-513.
15. Emmett E.A., Zhang H., Shofer F.S., Freeman D., Rodway N.V., Desai C., et al. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J. Occup. Environ. Med. 2006, 48:771-779. 10.1097/01.jom.0000233380.13087.37.
16. Eriksen H.-L.F., Kesmodel U.S., Underbjerg M., Kilburn T.R., Bertrand J., Mortensen E.L. Predictors of intelligence at the age of 5: family, pregnancy and birth characteristics, postnatal influences, and postnatal growth. PLoS One 2013, 8:e79200.
17. Fisher M., Arbuckle T.E., Wade M., Haines D.A. Do perfluoroalkyl substances affect metabolic function and plasma lipids?-Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1. Environ. Res. 2013, 121:95-103.
18. Fitz-Simon N., Fletcher T., Luster M.I., Steenland K., Calafat A.M., Kato K., et al. Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid. Epidemiology 2013, 24:569-576.
19. Fletcher T., Galloway T.S., Melzer D., Holcroft P., Cipelli R., Pilling L.C., et al. Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans. Environ. Int. 2013, 57-58:2-10.
20. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
21. Frisbee S.J., Shankar A., Knox S.S., et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch. Pediatr. Adolesc. Med. 2010, 164:860-869.
22. Geiger S.D., Xiao J., Ducatman A., Frisbee S., Innes K., Shankar A. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere 2014, 98:78-83.
23. Han X., Nabb D.L., Russell M.H., Kennedy G.L., Rickard R.W. Renal elimination of perfluorocarboxylates (PFCAs). Chem. Res. Toxicol. 2011, 25:35-46.
24. Haug L.S., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ. Sci. Technol. 2009, 43:2131-2136.
25. IARC Agents Classified by the IARC Monographs 2012, vols. 1-111.
26. Kato K., Wong L.-Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ. Sci. Technol. 2011, 45:8037-8045.
27. Kennedy G.J., Butenhoff J., Olsen G., O'Connor J., Seacat A., Perkins R., et al. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 2004, 34:351-384.
28. Kissa E. Fluorinated surfactants and repellents. Surfactant Science Series 97 2001, Marcel Dekker, New York (NY), (640 pp.). 2nd ed. revised and expanded.
29. Lin A.Y.-C., Panchangam S.C., Lo C.-C. The impact of semiconductor, electronics and optoelectronic industries on downstream perfluorinated chemical contamination in Taiwanese rivers. Environ. Pollut. 2009, 157:1365-1372.
30. Lin C.-Y., Chen P.-C., Lin Y.-C., Lin L.-Y. Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care 2009, 32:702-707.
31. Lin C.-Y., Wen L.L., Lin L.-Y., Wen T.-W., Lien G.-W., Chen C.-Y., et al. Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan. Environ. Sci. Technol. 2011, 45:10691-10698.
32. Lin A.-C., Panchangam S., Tsai Y.-T., Yu T.-H. Occurrence of perfluorinated compounds in the aquatic environment as found in science park effluent, river water, rainwater, sediments, and biotissues. Environ. Monit. Assess. 2014, 186:3265-3275.
33. Loveless S.E., Finlay C., Everds N.E., Frame S.R., Gillies P.J., O'Connor J.C., et al. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 2006, 220:203-217.
34. Mariussen E. Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance. Arch. Toxicol. 2012, 86:1349-1367.
35. Nelson J.W., Hatch E.E., Webster T.F. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ. Health Perspect. 2010, 118:197-202.
36. Olsen G., Zobel L. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int. Arch. Occup. Environ. Health 2007, 81:231-246.
37. Olsen G., Burris J., Ehresman D., Froehlich J., Seacat A., Butenhoff J., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
38. Pan W.-H., Wu H.-J., Yeh C.-J., Chuang S.-Y., Chang H.-Y., Yeh N.-H., et al. Diet and health trends in Taiwan: comparison of two nutrition and health surveys from 1993-1996 and 2005-2008. Asia Pac. J. Clin. Nutr. 2011, 20:238-250.
39. Peraza M.A., Burdick A.D., Marin H.E., Gonzalez F.J., Peters J.M. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol. Sci. 2006, 90:269-295.
40. Qazi M.R., Abedi M.R., Nelson B.D., DePierre J.W., Abedi-Valugerdi M. Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. Int. Immunopharmacol. 2010, 10:1420-1427.
41. Ruan T., Wang Y., Wang T., Zhang Q., Ding L., Liu J., Wang C., Qu G., Jiang G. Presence and partitioning behavior of polyfluorinated iodine alkanes in environmental matrices around a fluorochemical manufacturing plant: another possible source for perfluorinated carboxylic acids?. Environ. Sci. Technol. 2010, 44:5755-5761.
42. Sakr C.J., Kreckmann K.H., Green J.W., Gillies P.J., Reynolds J.L., Leonard R.C. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J. Occup. Environ. Med. 2007, 49:1086-1096. 10.1097/JOM.0b013e318156eca3.
43. Schecter A., Malik-Bass N., Calafat A.M., Kato K., Colacino J.A., Gent T.L., et al. Polyfluoroalkyl compounds in Texas children from birth through 12years of age. Environ. Health Perspect. 2012, 120:590-594.
44. Starling A.P., Engel S.M., Whitworth K.W., Richardson D.B., Stuebe A.M., Daniels J.L., et al. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study. Environ. Int. 2014, 62:104-112.
45. Steenland K., Tinker S., Frisbee S., Ducatman A., Vaccarino V. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am. J. Epidemiol. 2009, 170:1268-1278.
46. Steenland K., Fletcher T., Savitz D.A. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ. Health Perspect. 2010, 118:1100-1108.
47. Toms L.M.L., Thompson J., Rotander A., Hobson P., Calafat A.M., Kato K., et al. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011. Environ. Int. 2014, 71:74-80.
48. Tsai C., Huang J., Hwang B., Lee Y. Household environmental tobacco smoke and risks of asthma, wheeze and bronchitic symptoms among children in Taiwan. Respir. Res. 2010, 11:11. 10.1186/1465-9921-11-11.
49. Vestergren R., Berger U., Glynn A., Cousins I.T. Dietary exposure to perfluoroalkyl acids for the Swedish population in 1999, 2005 and 2010. Environ. Int. 2012, 49:120-127.
50. Wang J., Zhang Y., Zhang W., Jin Y., Dai J. Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents. Environ. Sci. Technol. 2012, 46:9274-9281.
51. Wang L., Wang Y., Liang Y., Li J., Liu Y., Zhang J., et al. Specific accumulation of lipid droplets in hepatocyte nuclei of PFOA-exposed BALB/c mice. Sci. Rep. 2013, 3.
52. Wang Z., CousinsIan T., Scheringer M., Buck R., Hungerbühler K. Global emission inventories for C4-C14 perfluoroalkyl carboxylic acid (PFCA) homologues from 1951 to 2030, part I: production and emissions from quantifiable sources. Environ. Int. 2014, 62:62-75.
53. Wolf C.J., Takacs M.L., Schmid J.E., Lau C., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths. Toxicol. Sci. 2008, 106:162-171.
54. Wolf C.J., Schmid J.E., Lau C., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds. Reprod. Toxicol. 2012, 33:546-551.
55. Zeng H.-C., Zhang L., Li Y.-Y., Wang Y.-J., Xia W., Lin Y., et al. Inflammation-like glial response in rat brain induced by prenatal PFOS exposure. NeuroToxicology 2011, 32:130-139.
56. Zhang L., Liu J., Hu J., Liu C., Guo W., Wang Q., et al. The inventory of sources, environmental releases and risk assessment for perfluorooctane sulfonate in China. Environ. Pollut. 2012, 165:193-198.